• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRPC6 突变与类固醇耐药性肾病综合征和非典型表型患儿相关。

TRPC6 mutations in children with steroid-resistant nephrotic syndrome and atypical phenotype.

机构信息

Department of Biomedical Sciences, University of Foggia, Viale Pinto, 1, 71100 Foggia, Italy.

出版信息

Clin J Am Soc Nephrol. 2011 Jul;6(7):1626-34. doi: 10.2215/CJN.07830910.

DOI:10.2215/CJN.07830910
PMID:21734084
Abstract

BACKGROUND AND OBJECTIVES

Mutations in the TRPC6 gene have been recently identified as the cause of late-onset autosomal-dominant focal segmental glomerulosclerosis (FSGS). To extend the screening, we analyzed TRPC6 in 33 Italian children with sporadic early-onset SRNS and three Italian families with adult-onset FSGS.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: TRPC6 mutation analysis was performed through PCR and sequencing. The effects of the detected amino acid substitutions were analyzed by bioinformatics tools and functional in vitro studies. The expression levels of TRPC6 and nephrin proteins were evaluated by confocal microscopy.

RESULTS

Three heterozygous missense mutations (c.374A>G_p.N125S, c.653A>T_p.H218L, c.2684G>T_p.R895L) were identified. The first new mutation, p.H218L, was found in a 18-year-old boy who presented a severe form of FSGS at the age of 8 years. The second, p.R895L, a new de novo mutation, was identified in a girl with collapsing glomerulosclerosis at the age of 2 years. The former mutation, p.N125S, was found in two siblings with early-onset steroid-resistant nephrotic syndrome (SRNS) at the ages of 4 and 14 years. Renal immunofluorescence revealed upregulated expression of TRPC6 and loss of nephrin in glomeruli. The intracellular calcium concentrations were significantly higher in the cells expressing all mutant TRPC6 channels compared with cells expressing wild-type TRPC6.

CONCLUSIONS

Our findings suggest that TRPC6 variants can also be detected in children with early-onset and sporadic SRNS (4 of 33 patients). Moreover, in one patient a new de novo TRPC6 mutation was associated with a rare severe form of childhood collapsing glomerulosclerosis with rapid progression to uremia.

摘要

背景和目的

最近发现 TRPC6 基因突变是导致晚发性常染色体显性局灶节段性肾小球硬化症(FSGS)的原因。为了扩展筛查范围,我们分析了 33 名意大利散发性早发性 SRNS 儿童和 3 个意大利家族性成人 FSGS 的 TRPC6。

设计、环境、参与者和测量:通过 PCR 和测序进行 TRPC6 突变分析。通过生物信息学工具和体外功能研究分析检测到的氨基酸取代的影响。通过共焦显微镜评估 TRPC6 和足细胞蛋白的表达水平。

结果

发现了三个杂合错义突变(c.374A>G_p.N125S、c.653A>T_p.H218L、c.2684G>T_p.R895L)。第一个新突变 p.H218L 发生在一名 18 岁男孩身上,他在 8 岁时表现出严重的 FSGS 形式。第二个新突变 p.R895L 发生在一名 2 岁患有塌陷性肾小球硬化症的女孩身上。前一个突变 p.N125S 发生在两个患有早发性类固醇抵抗性肾病综合征(SRNS)的兄弟姐妹身上,年龄分别为 4 岁和 14 岁。肾免疫荧光显示 TRPC6 表达上调,足细胞丢失。与表达野生型 TRPC6 的细胞相比,表达所有突变型 TRPC6 通道的细胞内钙离子浓度显著升高。

结论

我们的研究结果表明,TRPC6 变体也可在早发性和散发性 SRNS 儿童(33 例患者中的 4 例)中检测到。此外,在一名患者中,一种新的从头 TRPC6 突变与一种罕见的严重儿童期塌陷性肾小球硬化症相关,这种疾病迅速进展为尿毒症。

相似文献

1
TRPC6 mutations in children with steroid-resistant nephrotic syndrome and atypical phenotype.TRPC6 突变与类固醇耐药性肾病综合征和非典型表型患儿相关。
Clin J Am Soc Nephrol. 2011 Jul;6(7):1626-34. doi: 10.2215/CJN.07830910.
2
TRPC6 gene variants in Turkish children with steroid-resistant nephrotic syndrome.土耳其儿童激素耐药性肾病综合征中 TRPC6 基因突变。
Nephrol Dial Transplant. 2012 Jan;27(1):205-9. doi: 10.1093/ndt/gfr202. Epub 2011 Apr 21.
3
Bigenic heterozygosity and the development of steroid-resistant focal segmental glomerulosclerosis.双基因杂合性与类固醇抵抗性局灶节段性肾小球硬化的发生发展
Nephrol Dial Transplant. 2008 Oct;23(10):3146-51. doi: 10.1093/ndt/gfn208. Epub 2008 Apr 28.
4
TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis.大量局灶节段性肾小球硬化患者队列中的瞬时受体电位阳离子通道亚家族6(TRPC6)突变分析
Nephrol Dial Transplant. 2009 Oct;24(10):3089-96. doi: 10.1093/ndt/gfp229. Epub 2009 May 20.
5
CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS).CD2AP突变与散发性肾病综合征及局灶节段性肾小球硬化(FSGS)相关。
Nephrol Dial Transplant. 2009 Jun;24(6):1858-64. doi: 10.1093/ndt/gfn712. Epub 2009 Jan 7.
6
New TRPC6 gain-of-function mutation in a non-consanguineous Dutch family with late-onset focal segmental glomerulosclerosis.一个非近亲结婚的荷兰家族中发现新的 TRPC6 功能获得性突变,与晚发性局灶节段性肾小球硬化症有关。
Nephrol Dial Transplant. 2013 Jul;28(7):1830-8. doi: 10.1093/ndt/gfs572. Epub 2013 Jan 4.
7
Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome.NPHS2 分析在早发型和成人型激素抵抗性肾病综合征中的临床价值。
Clin J Am Soc Nephrol. 2011 Feb;6(2):344-54. doi: 10.2215/CJN.03770410. Epub 2010 Oct 14.
8
Mutational analysis of the PLCE1 gene in steroid resistant nephrotic syndrome.PLCE1 基因突变分析在激素耐药性肾病综合征中的作用。
J Med Genet. 2010 Jul;47(7):445-52. doi: 10.1136/jmg.2009.076166.
9
[Heterozygotic mutation in NPHS2 gene as a cause of familial steroid resistant nephrotic syndrome in two siblings--case report].NPHS2基因杂合突变导致两兄弟患家族性类固醇抵抗性肾病综合征——病例报告
Przegl Lek. 2006;63 Suppl 3:85-6.
10
Identification and functional analysis of a novel TRPC6 mutation associated with late onset familial focal segmental glomerulosclerosis in Chinese patients.中国患者中与迟发性家族性局灶节段性肾小球硬化相关的新型TRPC6突变的鉴定与功能分析
Mutat Res. 2009 May 12;664(1-2):84-90. doi: 10.1016/j.mrfmmm.2008.11.021. Epub 2008 Dec 13.

引用本文的文献

1
Delayed inactivation of TRPC6 as a determinative characteristic of FSGS-associated variants.TRPC6的延迟失活作为局灶节段性肾小球硬化相关变体的决定性特征。
J Biol Chem. 2025 May 21;301(6):110256. doi: 10.1016/j.jbc.2025.110256.
2
The Ca-actin-cytoskeleton axis in podocytes is an important, non-immunologic target of immunosuppressive therapy in proteinuric kidney diseases.足细胞中的钙-肌动蛋白-细胞骨架轴是蛋白尿性肾脏疾病免疫抑制治疗的重要非免疫靶点。
Pediatr Nephrol. 2025 Jan 25. doi: 10.1007/s00467-025-06670-z.
3
Genotype-Phenotype Correlations with TRPC6-Associated Podocytopathy.
与TRPC6相关足细胞病的基因型-表型相关性
J Am Soc Nephrol. 2025 Feb 1;36(2):177-180. doi: 10.1681/ASN.0000000598. Epub 2025 Jan 7.
4
Anti-Tumor Necrosis Factor Treatment for Glomerulopathy: Case Report and Review of Literature.抗肿瘤坏死因子治疗肾小球病:病例报告及文献综述
Fed Pract. 2024 Aug;41(8):250-255. doi: 10.12788/fp.0506. Epub 2024 Aug 15.
5
Natural History and Clinicopathological Associations of TRPC6-Associated Podocytopathy.与TRPC6相关的足细胞病的自然史及临床病理关联
J Am Soc Nephrol. 2025 Feb 1;36(2):274-289. doi: 10.1681/ASN.0000000501. Epub 2024 Oct 1.
6
Effective calcineurin inhibitor treatment in adult-onset steroid-resistant nephrotic syndrome with a novel splice donor site variant of TRPC6: a case report.成人起病的类固醇抵抗性肾病综合征伴TRPC6新型剪接供体位点变异的有效钙调神经磷酸酶抑制剂治疗:一例报告
CEN Case Rep. 2025 Apr;14(2):208-216. doi: 10.1007/s13730-024-00935-6. Epub 2024 Sep 30.
7
TRPC6 Knockout Alleviates Renal Fibrosis through PI3K/AKT/GSK3B Pathway.TRPC6 敲除通过 PI3K/AKT/GSK3β 通路减轻肾脏纤维化。
Curr Med Sci. 2024 Jun;44(3):589-602. doi: 10.1007/s11596-024-2869-z. Epub 2024 May 15.
8
Novel Pathogenic Mutation of P209L in TRPC6 Gene Causes Adult Focal Segmental Glomerulosclerosis.TRPC6 基因 P209L 新致病性突变导致成人局灶节段性肾小球硬化症。
Biochem Genet. 2024 Dec;62(6):4432-4445. doi: 10.1007/s10528-023-10651-y. Epub 2024 Feb 5.
9
An inactivating human TRPC6 channel mutation without focal segmental glomerulosclerosis.无局灶节段性肾小球硬化的人类 TRPC6 通道失活突变。
Cell Mol Life Sci. 2023 Aug 24;80(9):265. doi: 10.1007/s00018-023-04901-w.
10
Store-operated Ca channel signaling: Novel mechanism for podocyte injury in kidney disease.机械门控钙通道信号转导:肾脏病足细胞损伤的新机制
Exp Biol Med (Maywood). 2023 May;248(5):425-433. doi: 10.1177/15353702221139187. Epub 2022 Dec 19.